Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Front Cardiovasc Med · 2015 · PMC4668865 · PMID 26664875

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significantp = 0.08so close (0.05 < p ≤ 0.1)

This relatively large randomized controlled trial showed a borderline significant greater SBP reduction in the treatment arm compared to the placebo group (16 vs. 9 mmHg, respectively, p = 0.08) ( 90 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.